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ABSTRACT 
Objective: The objective of the research work was to develop liposomal gel of nadifloxacin in order to achieve better permeation and high drug 
retention into the deeper layers of the skin for effective treatment of acne vulgaris.  
Methods: Various formulations were developed using different ratios of cholesterol and phospholipid (F1-F6) and evaluated for particle size 
distribution, shape, zeta potential, poly dispersibility index, entrapment efficiency. The best liposomal formulation was then incorporated into 
carbopol gel base and evaluated for drug retention studies, in vitro, and ex-vivo permeation rate and other parameters. Results obtained were 
compared with marketed product.  
Results: Formulation (F1) with an equimolar ratio of lipid and cholesterol had vesicles in the size range of 2 to 6 µm, a large unilamellar structure 
with highest percent entrapment of 71±3.50. Formulation (F1) released 79±0.98% of the drug in 12h. Low drug retention in skin i. e 40±1.64 % was 
observed for marketed product whereas Liposomal formulation (F1) showed high drug retention of 80±1.45 % in skin layers. Zone of inhibition for 
developed liposomal gel (F1) was better was compared to marketed gel. Zeta potential was found to be-45.6 with a polydispersity index of 0.412 
indicating homogeneities and stability of vesicles.  
Conclusion: Developed liposomal formulation has better potential to treat acne due to high drug retention in skin layers. 
Keywords: Nadifloxacin, Liposomes, Acne, Dermal delivery. 




Acne is the common chronic skin disease affecting a high percentage of 
male and female population throughout the world. Acne is caused by 
Propionibacterium acnes and Staphylococcus aureus which is associated 
with inflammation and host immunological reactions [1, 2]. Although 
most of the conventional dosage forms like tablets, creams, gels, and 
ointments are available; they are failing in treating acne due to poor drug 
solubility and/or absorption, rapid metabolism, high fluctuation in the 
drug plasma variability due to food effect, less permeation through skin 
due to large globular size [3, 4]. To overcome these problems novel 
topical drug delivery system are preferable over conventional delivery 
systems. Novel topical drug delivery system includes liposomes and 
various types of liposomes such as liposomes, niosomes, ethos comes 
and transferosomes, microneedles, ultrasound and iontophoresis [5, 6]. 
Liposomes have high membrane fluidity which promotes penetration of 
the drug into deeper layers of the skin. Liposomes can deliver a large 
quantity of hydrophilic and lipophilic drugs, proteins, and 
macromolecules through the skin [7-9]. 
Nadifloxacin (NDF) is a fluoroquinolone with broad spectrum topical 
antibiotic [9] used in the treatment of multiple inflamed acne lesions. 
It shows bactericidal activity against propionibacterium acne and other 
gram positive and gram negative bacteria. The drug is poorly soluble 
in water with a log p of 2.47 [9, 10]. The liposomal system is most 
useful for the treatment of acne as it improves the skin attachment and 
consequently, enhances the accumulation of antibacterial agent in the 
target area [11]. The maximum amount of drug encapsulation and 
small vesicle size helps in maximum penetration of drug and produce 
sustained release effect at the site [12]. 
Hence the main aim of our research work was to determine the 
potential of liposome-based gel for dermal delivery of nadifloxacin 
so as to enhance penetration of the drug into the deeper layers of the 
skin, controlled drug release, and high retention in the skin layers. 
MATERIALS AND METHODS 
Materials 
Nadifloxacin (NDF) was gift sample from Cipla R and D Center 
Mumbai, India, phospholipon 90H was gift sample from Lipoid GmbH 
Germany GmbH Germany, potassium dihydrogen phosphate, sodium 
hydroxide, ethanol, methanol, chloroform, cholesterol purchased from 
SD fine chemicals, Mumbai, India. Dialysis membrane (DM-70 
Molecular weight cut-off 12000) and Mueller-Hinton agar were 
purchased from Hi-media, Mumbai, India. Staphylococcus aureus ATCC 
No. 6538 was purchased from National Chemical Laboratory, Pune, 
India. All the chemicals used were of analytical grade. Double distilled 
water was used throughout the studies. 
Methods 
Preparation of nadifloxacin liposomes 
NDF loaded liposomes were prepared by thin film hydration 
technique. The lipid mixtures and drug were placed in the 100 ml 
round bottomed flask and dissolved by using chloroform: methanol. 
The organic solvent was evaporated by using Heidolph-Laborota 
4001 rotary evaporator GmbH, Germany, connected to a single stage 
vacuum pump. Temperature and RPM were set at 45оC and 60 
respectively. Thin film obtained was then hydrated with 10-15 ml of 
phosphate buffer 6.8pH for a period of 1h [13, 14]. 
 
Table 1: Composition of liposomal formulation 
Formulation Nadifloxacin (mg) Phospholipon 90H (µM) Cholesterol (µM) Methanol (ml) Chloroform (ml) 
F1 10 200 200 3 9 
F2 10 250 150 3 9 
F3 10 300 100 3 9 
F4 10 350 50 3 9 
F5 10 150 250 3 9 
F6 10 100 300 3 9 
* Total 400 µM lipid mixture was used in all the preparations 
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Characterization of liposomal formulation 
Vesicle shapes determination 
The prepared liposomal formulation was placed on a slide, fixed by 
using cover slip and observed for liposomes using phase contrast 
microscope (HL-23, Coslab) under 450X magnification, magnified 
images of liposomes were captured. 
Entrapment efficiency 
Aliquots of liposomal formulations were subjected to centrifugation 
using cooling centrifuge (Remi Equipments Pvt. Ltd, Mumbai, India) at 
2,500 rpm for about 2 h. The clear supernatant was then separated 
carefully to separate the unentrapped nadifloxacin and sediment was 
then treated with 1 ml of methanol to lyse the vesicles and diluted to 
10 ml with methanol and absorbance of both solutions was observed 
at 292 nm. The amount of nadifloxacin in supernatant and sediment 
gave a total amount of nadifloxacin in 1 ml of dispersion [15-18]. The 
percent entrapment was calculated using the formula, 
% E. E =
Amount of nadifloxicin in sediment 
Amount of 
nadifloxicin added
100 … … (1) 
Drug content 
The prepared liposomal formulations were taken in a test tube, to 
this 10 ml of methanol was added to lyse liposomes which could 
release the entrapped drug. The amount of nadifloxacin was 
determined by using U. V-Visible spectrophotometer (Spectro UV 
2080, Double beam, Analytical Technologies, India) at 292 nm and 
amount present in the formulations were calculated [19, 20]. 
Preparation of liposomal gel 
Carbopol gel 1% w/v base was prepared by dispersing 1 g of 
carbopol 934 in 100 ml of distilled water. Prepared liposomal 
formulation was incorporated into neutralized carbopol 934 gel 
base to get nNadifloxacin loaded liposomal gel (NDF LG) 1% w/w. 
Characterization of liposomal gel 
The prepared gels (F1-F6) were inspected visually for their color, 
appearance, and consistency [21, 22]. The pH of the gel was measured on 
a digital pH meter (Systronic equipment Pvt. Ltd, Ahmedabad, India) at 
ambient temperature. Before the measurement pH meter was 
standardized using, phosphate buffer 6.8 pH and triplicates were done. 
The rheological analysis of the liposomal gel of nadifloxacin was 
performed using a Brookfield viscometer DV-II+PRO (Viscolab 3000, 
Mumbai, India), equipped with standard spindle LV3 with spindle code 
63. Viscosity was done in triplicates, and the mean value was calculated 
at 100 rpm [23]. Spreadability was determined by apparatus suggested 
by Mutimer et al. [1956] Two slides were taken; 3g of a gel was placed on 
one slide another glass slide was placed such that gel was sandwiched 
between two glass slides. The top slide was subjected to a stress of 50 g 
by putting weight on it. The time (in seconds) required by the gel to 
travel a distance of 10 cm was noted, shorter time interval indicates 
better spreadability [24]. 
In vitro diffusion study 
In vitro drug, diffusion study was performed using Franz diffusion cell. 
Dialysis membrane was placed between receptor and donor 
compartments and a single dose equivalent liposomal formulation was 
placed on it; receptor compartment was filled with phosphate buffer 
pH 6.8 (15 ml). The diffusion cells were maintained at 37±0.5 °C with 
stirring at 600 rpm. (Remi Equipment Pvt. Ltd, Mumbai, India) At fixed 
time interval, 1 ml of the aliquot was taken for every 1, 2, 3, 4, 5, 6, 7, 8, 
9, 10 and 12 h from receiver compartment through side tube and an 
aliquot was replaced with fresh medium. The samples were analyzed 
using U. V-Visible spectrophotometer [25, 26]. Drug flux (µg/h/cm2) at 
steady state was calculated by dividing the slope of the steady state 
portion of the line in the plot drug amount permeated per unit area of 
dialysis membrane verses time. 
Ex vivo diffusion study 
An ex vivo drug release study was performed using Franz diffusion 
cell. Porcine ear skin was placed between receptor and donor 
compartment. Liposomal suspension and gel equivalent to one dose 
were placed on porcine ear skin in the donor compartment whereas 
the receptor compartment was filled with phosphate buffer pH 6.8 
(15 ml). The diffusion cells were maintained at 37±0.5 °C with 
stirring at 600 rpm (Remi Equipment Pvt. Ltd, Mumbai, India). At 
fixed time interval, 1 ml of aliquots was taken for every 1, 2, 3, 4, 5, 6, 
7, 8, 9, 10, 11, 12 h from receiver compartment through side tube 
and an equal aliquot was replaced and analyzed [27, 28]. 
Estimation of drug retained in the skin layers 
After completion of ex vivo studies, the skin was removed from the 
diffusion cells and the surface of skin specimens was washed with 1 ml 
of distilled water 8-10 times. The amount of drug present in the 
resultant solution was determined by UV-Visible spectrophotometry. 
Epidermis and dermis layers were separated by heat method [29, 30]. 
Skin specimens were placed in a sealed bag and placed in water 
maintained at 50 °C for 30 s. Dermis was separated by peeling after 
completion of 30 s. The separated skin layers were minced with a 
sterile surgical scalpel and placed in 10 ml methanol and vortexed for 
5 min. Tissue suspensions were then centrifuged at 10,000 rpm for 15 
min and the supernatant was filtered. Filtered supernatant tissue 
suspension was again extracted with methanol and filtered. The 
filtrate was analyzed by UV-Visible spectrophotometry. 
Stability study 
The prepared liposomal formulations were stored at room 
temperature (27±5 °C) and refrigeration (2-8 °C) for a period of 3 
mo, and then visually observed for clearance of every month. 
Evaluation of antibacterial activity 
Antimicrobial activity for NDF in the optimized formulation i. e NDF-
LG, placebo gel, and the marketed product was evaluated against 
Staphylococcus aureus ATCC No. 6538 by using cup plate method. 
Mueller-Hinton agar plates were prepared by pouring 10-15 ml of 
the medium into each sterile petri dish and were allowed to set at 
room temperature. The final concentration of micro-organisms in 
the inoculums was adjusted to108cfu/ml and inoculated in the agar 
medium using a sterile inoculation loop. Sterile borer was used to 
form cups in each plate. Sample equivalent to 0.2% w/w NDF was 
quantitatively transferred to these plates. Positive control and 
negative control plates were also maintained to confirm the results. 
The Petri plates were then incubated in the anaerobic jar at 37 °C for 
48 h. After incubation zones with complete inhibition were 
measured and diameters of the same recorded with the help of a 
measuring scale. Mean zone of inhibition was recorded for all the 
test samples and statistically analyzed using one-way ANOVA 
followed by Bonferroni’s multiple comparison tests at (*P<0.05) 
significance level [8, 9]. 
Determination of particle size and zeta potential 
The mean size and size distribution of Formulation F1 was determined 
by photon correlation spectroscopy using Zetasizer Nano ZS (Malvern 
Instruments CO, UK). The samples were diluted to a suitable 
concentration with filtered double distilled water. Size analysis was 
performed at 25 °C with an angle of detection of 90 °C. Size, 
polydispersity index was obtained directly from the instrument [31, 32]. 
Statistical analysis 
The statistical analysis was performed using One-way analysis of 
variance (ANOVA) using Graph Pad prism software (Graph Pad Prism 
version 7.0.0.159, USA). One-way ANOVA followed by Bonferroni’s 
multiple comparison tests was applied for determining the statistically 
significant difference in antibacterial activity between various 
formulations. The values obtained for formulations at a P value of 0.05 
was considered to be statistically significant. The characterization data 
were expressed as the means of three experiments±SD [31, 32]. 
RESULTS AND DISCUSSION 
Characterization of liposomes 
Vesicle shapes determination 
From fig. 1 it is evident that the shape of liposomal (F1-F6) 
formulations was uniform and spherical showing multilamellar, 
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onion peel structure to large and small unilamellar vesicles. The 
shape and size of the vesicles were dependent on the ratio of 
phospholipid and cholesterol used in the formulation. 
Liposomal formulation (F2) containing 250 µM of phospholipon 90H 
and 150 µM of cholesterol showed multilamellar vesicles (MLV) with 
many liposomal vesicles. While formulation F5, MLV with onion peel 
structure is observed with reverse concentrations with the 
equimolar concentration of phospholipon 90H and 150 µM of 
cholesterol large unilamellar vesicles (LUV) were observed for 
formulation F1. Liposomes obtained for formulation F6 were 
medium sized, whereas formulation F4 showed large unilamellar 
vesicles (LUV), liposomal vesicles are denoted by an arrow in the 
respective figures. 
Vesicle size is of great importance in the case of vesicular systems. 
The concentration of cholesterol might have influenced the size of 
vesicles. In this investigation, we could notice that F1 formulation 
with an equimolar ratio of lipid and cholesterol had a small size. The 
mean size of vesicles was in the range of 4 to 10 µm; it can also be 
noted that increasing cholesterol content subsequently decreased 
mean vesicle size and this may be due to increasing in the 
hydrophobicity of bilayers which limits the water intake to the 
vesicles core [31, 32]. 
 
 
Fig. 1: Phase contrast optical images of various liposomal formulations at 450 X magnification 
 
Entrapment efficiency 
The entrapment efficiency of all the formulations was determined 
using UV-Visible spectrophotometer at a wavelength of 292 nm. 
Formulation (F1) showed highest percent entrapment of drug i. e 
71±3.50% as compared to other formulation F2, F3, F4, F5 and F6 
that showed 61±3.12%, 60±2.35%, 57±0.56%, 52±0.56% and 
47±0.98% respectively. 
The concentration of cholesterol and phospholipid has a great influence 
on entrapment efficiency Formulation F1 consisting of an equimolar 
concentration of cholesterol and phospholipid showed high entrapment 
efficiency. Phospholipid is an important component for bilayer formation 
while cholesterol increases the bilayer hydrophobicity as well as 
improves the stability of liposomes. Reduced permeability of the bilayer, 
leads to the effective entrapment of hydrophobic drug within the 
hydrophobic core of the bilayer. However, formulation F5 and F6 
showed low entrapment in spite of high concentration of cholesterol 
used as this formulation had very low concentration of phospholipid. It 
can be explained in a way that packing space available in the bilayer is 
limited and due to higher amounts of cholesterol present in those 
formulations might have occupied the entire space leaving less scope for 
entrapment of drug [31-35]. 
Drug content 
The drug content of all developed liposomal formulations was within 
the limits. No signs of drug degradation were observed when the 
dispersion of liposomes was incorporated in carbopol gel base. 
Characterization of liposomal gel 
There was no significant difference found between the viscosities of 
all six formulations it was in the range of 27,124±3.1-31,768±0.76. 
The pH of the liposomal gel was in the acceptable range of 5.5-6.3 
which were compatible for dermatological use. All developed 
formulations had good spreadability as the time taken by the slide to 
travel a distance of 10 cm was less than one min as compared to 
marketed cream. The spreadability of the developed formulation 
may have improved because of carbopol which results in the loose 
matrix of gel compared to the cream base.  
In vitro diffusion study 
Among the different liposomal formulations, F1 showed 72.32% 
drug release at the end of 12h of diffusion (fig. 2). Consequently, 
diffusion was higher for F1 formulation as compared to F2, F3, F4, 
F5, F6 and marketed formulations which showed drug release of 
59.38±0.64, 56.25±1.29, 53.21±1.79, 51.15±1, 53.88±1.64, and 
39.03±2.50 respectively. It is evident from the data that there is 
enhanced diffusion rate for liposomal formulations than 
conventional marketed cream. Calculated flux for F1 formulation 
was 5.21±0.81µg/h/cm2, while that of marketed product was 
2.85±0.85 µg/h/cm2. On the basis of this data F1 formulation 
containing an equimolar ratio of phospholipon 90H and cholesterol 
was selected for further studies. The enhanced diffusion rate for 
liposomal formulation would be due to the vesicle size. Narrow 
vesicle size range results in improved diffusion through the 
membrane. Conventional creams have larger droplet size which 
restricts the permeation of drug through the membrane [9]. 
Ex vivo diffusion study 
From the studies (fig. 3) it was observed that after 12 h percentage 
drug release for F1 (liposomal dispersion), F1 (liposomal gel) and 
marketed formulation were found to be 77.58±1.3%, 66.98±1.5, and 
39.03±0.89% respectively. F1 liposomal gel showed the better-
controlled release of drug as compared to marketed product. [33]. 
This can be explained in a similar way as that of in vitro diffusion 
studies, the vesicle size obtained for liposomal formulation was in 
the range of 4-6 µm which helps penetration of the drug into deeper 
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layers of skin. The hydrophilic nature of liposomal gel also enhances 
hydration of skin which improves further permeation by hydrating 
stratum corneum and increasing uptake of nadifloxacin. Marketed 
cream on the other hand results in decrease permeation of drug due 
to large droplet size which fails to penetrate through stratum 
corneum and remains more on the surface of skin [9]. 
 
 
Fig. 2: In vitro diffusion studies of developed liposomal gels and marketed product 
 
 
Fig. 3: Ex-vivo diffusion studies 
 
Estimation of drug retained in the skin layers 
From fig. 4 it is observed that formulation F1 (liposomal gel) showed 
high retention of drug in skin layers such as dermis and epidermis 
(81.31 %) and very low amount of drug was diffused through the 
skin which would lead to systemic circulation (approximately 
19.03%). Marketed product, on the other hand, showed only 40.07% 
of drug retention in skin layers because of it large droplet size which 
is usually in the range of 10-100 µm. From the results, it can be 
concluded that liposome as a carrier not only act as a penetration 
enhancer for NDF but also promotes high localization of drug within 
the skin due to its small vesicle size [32, 33]. 
 
 
Fig. 4: Drug retention in skin layers 
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The stability data suggests that formulations stored at ambient 
temperature (i.e. room temperature) showed the signs of instability 
either due to phase separation or increment in particle size or 
presence of crystals. Formulations stored at refrigeration conditions 
(at 2-8 °C) sedimentation was observed which upon re-dispersion 
resulted in translucent to off-white solutions. Indicating that the 
storage of liposomes at refrigeration conditions was more preferable 
compared to room temperature but at the cost of increment in the 
particle size which suggests the instability of liposomes in aqueous 
dispersions and further suggests that the liposomes should be freeze 
dried in order to prevent the instability problems and to retain its 
characteristics [33, 34]. 
Antibacterial activity 
Cup plate method depends on the principle of diffusion of antibiotic from 
the bore through the solidified agar preventing the growth of the 
microorganism in the form of the zone around the circle in which 
antibiotic, or sample is placed. Data obtained for antimicrobial activity is 
shown in fig. 5. Zone of inhibition for NDF-LG (F1 formulation) was high 
as compared to marketed product. A number of colonies seen 
throughout the Petri plate is less whereas in marketed product colonies 
formed are dense. Such enhanced in vitro antibacterial activity of NDF LG 
may be attributed due to enhanced penetration or diffusion of liposome 
from the gel base throughout the media. The one-way ANOVA followed 
by Bonferroni’s multiple comparison tests shows that formulation F1 ie. 
Nadifloxacin liposomal gel showed statistically significant antibacterial 
activity at (*P<0.05) significant level compared to conventional marketed 
product [9]. 
Determination of particle size and zeta potential 
The average particle size of the F1 formulation was found to be 
4-6 µm with a polydispersity index of 0.412 and zeta potential 
of-45.6. Low polydispersity index indicates homogeneity of 
vesicles. Zeta potential is a key factor signifying stability of 
liposomal dispersions. The magnitude of zeta potential 
represents the degree of electrostatic repulsion between 
particles that prevents particle aggregation or fusion. If the zeta 
potential value is above-30mV the dispersion is considered to be 
stable since the electric repulsion between the particles is high 
[32-34]. The value obtained for zeta potential was sufficient 
enough to control the stability of developed liposomal 
formulation. Negative charge obtained on the surface of vesicles 
may be probably due to the neutral charge on the phospholipids 




Fig. 5: Zone of inhibition of different samples, A = Marketed product B = F1 Nadifloxacin loaded liposomal gel, C = Negative control, D = 
Placebo gel 
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Fig. 6: Particle size distribution and zeta potential 
 
CONCLUSION 
Nadifloxacin loaded liposomal gels were successfully formulated using 
various ratios of phospholipon 90 H and cholesterol. Formulation F1 
gave vesicles with desired particle size of 4-6 µm which is required for 
better penetration in deeper layers of skin. Low poly dispersibility 
index and Zeta potential of-45.6 showed good homogeneity and 
stability of developed liposomes. Drug loaded liposomal gel(F1) 
containing 1:1 ratio of phospholipid and cholesterol showed high 
entrapment efficiency, better penetration and high drug retention in 
skin layers as compared to marketed product. From the data obtained 
from research work, it can be concluded that liposomes as a carrier 
have good potential to treat chronic skin diseases effectively as 
compared to conventional dosage forms. 
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